Ibritumomab Intravenous and Orencia (Abatacept Infusion)
Determining the interaction of Ibritumomab Intravenous and Orencia (Abatacept Infusion) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: abatacept
Brand name: Orencia, Orencia ClickJect, Orencia Prefilled Syringe
Synonyms: Orencia
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Orencia (Abatacept Prefilled Syringes)
- Ibritumomab Intravenous-Orenitram
- Ibritumomab Intravenous-Orfadin
- Ibritumomab Intravenous-Orfadin (Nitisinone Capsules)
- Ibritumomab Intravenous-Orfadin (Nitisinone Oral Suspension)
- Ibritumomab Intravenous-Orfadin Suspension
- Orencia (Abatacept Infusion)-Ibritumomab Tiuxetan
- Orencia (Abatacept Infusion)-Ibrutinib
- Orencia (Abatacept Infusion)-Ibrutinib Capsules
- Orencia (Abatacept Infusion)-Ibrutinib Tablets
- Orencia (Abatacept Infusion)-Ibu
- Orencia (Abatacept Infusion)-IBU Tablets